Immunohistochemical (IHC) staining for ERG is utilized as a surrogate for
TMPRSS2: ERG gene fusions, a specific molecular event seen in ~50% of prostate carcinomas
(PCas) and ~20% of high-grade prostatic intraepithelial neoplasia (HGPIN)
intermingled with adjacent PCa demonstrating identical gene fusions.
To read the rest of this article, please
contact Inform Diagnostics